20 insiders have filed at ACAD since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Baker Bros. Advisors Lp | Director | 39.47M | 22.853% | ||
| Baker Julian | Director | 39.47M | 22.853% | ||
| Baker Felix | Director | 39.47M | 22.853% | ||
| Baker Bros. Advisors (gp) Llc | Director | 39.47M | 22.853% | ||
| 667, L.P. | Director | 39.47M | 22.853% | ||
| Baker Brothers Life Sciences Lp | Director | 39.47M | 22.853% | ||
| Davis Stephen | CEO | 186.6k | 0.108% | 11 sells $7.6M | |
| Teehan Brendan | EVP, COO, Head Of Commercial | 62.1k | 0.036% | 8 sells $666k | |
| Schneyer Mark C. | EVP, Chief Financial Officer | 60.3k | 0.035% | 20 sells $2.2M | |
| Kim Austin D. | EVP,general Counsel, Secretary | 46.9k | 0.027% | 2 sells $377k | |
| Soland Daniel B | Director | 44.0k | 0.026% | ||
| Harrigan Edmund | Director | 35.0k | 0.02% | ||
| Kihara James | Principal Accounting Officer | 26.9k | 0.016% | 18 sells $579k | |
| Garofalo Elizabeth A. | Director | 25.4k | 0.015% | 2 sells $131k | |
| Ndu Adora | Director | 24.8k | 0.014% | ||
| Brege Laura | Director | 15.1k | <0.01% | 1 sells $315k | |
| Owen Adams Catherine | Chief Executive Officer | 14.8k | <0.01% | 1 sells $250k | |
| Rhodes Jennifer J | EVP, Chief Legal Officer, Sec | 11.3k | <0.01% | 2 sells $245k | |
| Daly James M | Director | 4.0k | <0.01% | 1 sells $671k | |
| Thompson Elizabeth H.Z. | EVP, Head Of Research & Dev | 3.3k | <0.01% | 1 sells $74k |
Full register at boothcheck.com/insiders/ACAD. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.